Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A

Ítems similars

• Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells
  per: Doering, Christopher B., et al.
  Publicat: (2010)
• Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
  per: Ide, Lucienne M., et al.
  Publicat: (2007)
• Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A
  per: Brown, Harrison C., et al.
  Publicat: (2018)
• Effects of FVIII immunity on hepatocyte and hematopoietic stem cell–directed gene therapy of murine hemophilia A
  per: Lytle, Allison M, et al.
  Publicat: (2016)
• Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A
  per: Doering, Christopher B., et al.
  Publicat: (2018)